Published in Drug Week, September 9th, 2005
According to recent research from Spain, "Patients who have experienced a recent major bleeding episode are usually excluded from clinical studies of VTE treatment. Therefore, recommendations based on evidence from clinical trials may not be suitable for these patients."
"The Registro Informatizado de la Enfermedad TromboEmbolica (RIETE) is a multicenter, observational registry designed to gather and analyze data on VTE treatment practices and clinical outcomes in patients with acute VTE. The aim of this analysis was to study outcomes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.